(Q24240244)

PubMed

PubMed publication ID

19821281

30 October 2023

Rosalind L Smyth

series ordinal

2

author given names

Rosalind L

author last names

Smyth

1 reference

PubMed

PubMed publication ID

19821281

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

7 October 2009

0 references

published in

0 references

cites work

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Influenza vaccination in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Effects of upper respiratory tract infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Impact of influenza on morbidity in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

Comparison of live and inactivated influenza vaccine in high risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

7 January 2021

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

7 January 2021

Influenza immunization in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

7 January 2021

Liposomal influenza vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB2

7 January 2021